Cystatin C and sudden cardiac death risk in the elderly

Rajat Deo1, Nona Sotoodehnia, Ronit Katz

  • 1Division of Cardiology, University of Pennsylvania, Philadelphia 19104, USA. Rajat.Deo@uphs.upenn.edu

Insights

Kidney dysfunction, indicated by cystatin C levels, independently increases sudden cardiac death risk in older adults without heart disease. Creatinine-based measures did not show this independent association.

Area of Science:

  • Cardiology
  • Nephrology
  • Epidemiology

Background:

  • Emerging evidence links moderate kidney dysfunction to sudden cardiac death (SCD) in individuals with cardiovascular disease.
  • Understanding kidney function's role in SCD risk is crucial for preventative strategies.

Purpose of the Study:

  • To investigate the independent association between kidney function markers and the risk of sudden cardiac death (SCD) in an elderly population without pre-existing cardiovascular disease.
  • To compare the predictive value of cystatin C and creatinine-based estimated glomerular filtration rate (eGFR) for SCD.

Main Methods:

  • Longitudinal analysis of 4465 participants from the Cardiovascular Health Study without prevalent cardiovascular disease at baseline.
  • Measurement of serum cystatin C and creatinine to assess kidney function.
  • Adjudication of sudden cardiac death (SCD) events over an 11.2-year median follow-up, analyzed using multivariate Cox proportional hazards models.

Main Results:

  • An increased annual incidence of SCD events was observed across increasing cystatin C tertiles (32 events per 10,000 person-years in the highest tertile).
  • Higher cystatin C levels demonstrated a persistent, independent association with increased SCD risk after multivariate adjustment (HR=2.67, 95% CI: 1.33-5.35 in the highest tertile).
  • While creatinine-based eGFR showed a trend of increasing SCD incidence across tertiles, no significant independent association with SCD remained after multivariable adjustment.

Conclusions:

  • Kidney dysfunction, as assessed by cystatin C, is an independent predictor of sudden cardiac death (SCD) risk in elderly individuals without clinical cardiovascular disease.
  • Cystatin C appears to be a more robust marker than creatinine-based eGFR for identifying individuals at higher risk of SCD in this population.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...